|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.3 USD | +1.63% |
|
-0.72% | -10.36% |
| 05-23 | Some of the biggest splits in Corporate America | RE |
| 05-22 | Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies | RE |
Kenvue Inc. re-affirmed earnings guidance for the year 2024. For the year, Based on current spot rates, company reaffirmed full year 2024 reported Net sales growth to be in the range of 1.0% to 3.0%. Foreign exchange is expected to be a headwind of approximately one percentage point to reported Net sales growth.
The Company continues to expect full year 2024 Organic growth in the range of 2.0% to 4.0%.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.36% | 36.36B | |
| +12.28% | 384B | |
| +12.61% | 136B | |
| +16.62% | 74.6B | |
| -12.57% | 66.27B | |
| -15.65% | 43.53B | |
| +6.37% | 34.72B | |
| +7.80% | 17.91B | |
| +12.30% | 15.64B | |
| -2.17% | 11.73B |
KENVUE INC. 
